{{ storiesRelated.title }}

Full List Of Stories
11 Oct
pod point at tesco
Electric vehicle charging firm Pod Point plans London listing

UK electric vehicle charging group Pod Point has revealed plans for a London stock market listing as it seeks to capitalise on a petrol and diesel vehicle ban in 2030.

11 Oct
Glaxosmithkline, GSK, drugs, pharmaceuticals
Glaxo unveils plans for £120m consumer healhcare HQ ahead of split

GlaxoSmithKline on Monday unveiled plans for a new £120m base for its consumer healthcare operations as it prepares to split into two listed firms.

11 Oct
glencore, mining, commodities, metals, mine, smelter
Europe midday: Shares down as investors fret over inflation; Asos slumps

European stocks were slid lower at midday on Monday as investors fretted about persistent inflationary pressure while rising commodity prices lifted mining and energy shares.

11 Oct
johan sverdrup oilfield north sea
Europe open: Shares flat as oil prices surge, Asos slumps

European stocks were flat at the opening of the week as investors stayed on the sidelines ahead of the third quarter earnings season and a surge in commodity prices boosted miners.

11 Oct
grande-bretagne-des-militants-ecologistes-entendent-perturber-le-trafic-aerien-a-heathrow 20200227132223
Heathrow Sept passenger numbers at 38% of 2019 levels

London’s Heathrow airport on Monday said September passenger numbers hit 38% of pre-pandemic levels, as it called for the UK to expand the use of sustainable aviation fuels to cut carbon emissions.

11 Oct
dl royal dutch shell oil fuel tanker transport petrol gas gasoline energy ftse 100 min
Seeing Machines to provide driver distraction tech for Shell fleet

Seeing Machines said it had signed an agreement with oil giant Shell to supply its driver distraction and fatigue technology.

11 Oct
treatt tea
Healthier living helps drive Treatt revenue rise

Food and fragrance ingredient supplier Treatt said it expected annual revenue to rise around 14%, helping it to meet earnings guidance provided in May.

11 Oct
coronavirus casse tete sur la 2e dose apres les restrictions pour le vaccin d astrazeneca
AstraZeneca antibody cocktail shows reduced risk of Covid infection

AstraZeneca said its antibody cocktail to combat Covid-19 had achieved a “statistically significant reduction” in the risk of developing the virus or death in a phase 3 trial.